This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included.
However, the TACT2 results did not reveal any difference in the composite primary outcome of death from any cause, heart attack, stroke, coronary revascularization or hospitalization for unstable angina among people who received weekly edetate disodium-based infusions compared with those who received a placebo. and Canada.
Background:Obesity has been associated with an increase in the risk of stroke and poor outcomes. Trends, demographics, comorbidities, and outcomes were then compared between the two cohorts.Results:Overall Prevalence of stroke was higher in the MHO-ve cohort (2.4% p<0.001) compared to the MHO+ve cohort.
We aim to examine the real-world effectiveness of early versus delayed post-discharge SGLT2 inhibitor initiation in people with acute heart failure and type 2 diabetes. The primary outcome was hospitalization for heart failure (HHF) or cardiovascular mortality as a composite. Follow-up started from discharge for maximum 1 year.
Introduction:The paucity of large-scale data exploring the effect of prior bariatric surgery on recurrent stroke outcomes in elderly obese stroke survivors led us to address the gap, with an emphasis on the risk of recurrent stroke and its trends.Methods:A retrospective study was conducted using National Inpatient Sample data from 2016-2019.
This study evaluates the outcomes in patients admitted for HF with and without hyperkalemia.Methods:We used the Nationwide Readmissions Database (NRD) from 2016-2019, extracting adult patients with a primary diagnosis of HF who were admitted between January and November of each year. vs. 2.5%, p < 0.001). 2], p<0.001).Conclusion:Hyperkalemia
Introduction:Studies have reported racial disparities in acute stroke treatment and follow-up care in young patients which lead to less desirable outcomes for minorities. A logistic regression was used to evaluate the odds ratio of favorable functional outcomes (mRS 2) by 90 days. male, covering 57.2% BL, and 20.4% BL, and 20.4%
We used logistic regression to determine the relationship between screening rates of syphilis and patient age and race.Results:Between 2016-2020, there were 5,653 stroke admissions without established infection. between 2016-2019, but then dropped to 1.02% in 2020. Annual screening rates increased from 0.44% to 2.5%
However, its postoperative complications can have a significant effect on long-term patient outcomes. AUC, or area under the receiver operating characteristic curve, quantifies the ability of a model to distinguish between positive and negative outcomes.
There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] I think we live in a very exciting time right now for those who work in diabetes and cardiovascular disease.
There was no increase in new onset diabetes mellitus or worsening of diabetes mellitus. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. 2016 Nov 28;7:13457. Treatment discontinuation was similar to placebo. Another interesting aspect is that bempedoic acid treament reduced hsCRP levels by 21.6%
Many studies have aimed to determine if heart failure (HF) is an independent risk factor in the development of AIS, but there is a paucity of literature describing the interventions and functional outcomes in this group of patients. 24.2%, p < 0.001), diabetes mellitus (39.7% 27.3%, p < 0.001), male (61.8%
Ancel Keyes in 1963 published pivotal research that for the first time associated the diet with improved health outcomes, more specifically, showed a correlation between the traditional Mediterranean diet and a lower risk of coronary heart disease. This study helped to solidify the place of the Mediterranean diet in the medical community.
Introduction:There is no established acute intervention for central retinal artery occlusion (CRAO) which often results in poor visual outcomes. More patients had diabetes in tPA (52.6%) vs TNK (13.3%) vs MM (29.0%) p=0.04. Intravenous Alteplase (tPA) has emerged as a promising acute treatment for CRAO. vs. 68.214.4 yrs) p=0.04.
Patients with diabetes (aOR, 95% CI: 2.99, 1.25-7.15) We longitudinally followed the patients by linking the registry data to the Center for Medicare&Medicaid Service (CMS) claims data. Model fit was assessed using the Hosmer-Lemeshow test.Results:Among 142 eligible pre-ICH statin users (median age [IQR]: 77.5 [72-86] female; 66.0%
BackgroundMeta‐analyses of large clinical trials investigating SGLT2 (sodium‐glucose cotransporter‐2) inhibitors have suggested their protective effects against atrial fibrillation in patients with type 2 diabetes. An active‐comparator, new‐user design was used, and the 2 groups of patients were matched using propensity scores.
To look more closely at associations between cannabis use and health, Jeffers and her research team used 2016–2020 data from the Behavioral Risk Factor Surveillance Survey of the Centers for Disease Control and Prevention. However, there are gaps in knowledge about the adverse effect of cannabis on the heart. states and two territories.
Patient and hospital-level characteristics associated with use and outcome of reperfusion therapies were analyzed. Patient and hospital-level characteristics associated with use and outcome of reperfusion therapies were analyzed. Favorable discharge outcome occurred in 65.8% of all mild strokes and in 56.9%
times more likely to have a favorable outcome than those who do not achieve this goal. The final models included 1,317 patients with available MRS data and 1,789 patients with available discharge disposition data respectively. p = 0.90, 95% CI = [-0.9, There was no affect of DTD</=90 on length of stay or discharge to home.
The primary clinical outcomes were all‐cause mortality during same admission. Secondary safety outcomes included intracranial hemorrhage (ICH), seizures, gastric tube (G‐tube) insertion, > 24‐hours mechanical ventilation, tracheostomy, length of stay (LOS), and discharge location (home vs. others).
Outcomes included favorable disposition (discharged to home) and in-hospital mortality.Results:Among 68,975 of stroke MT with recorded NIHSS during the study period (51.1% Outcomes included favorable disposition (discharged to home) and in-hospital mortality.Results:Among 68,975 of stroke MT with recorded NIHSS during the study period (51.1%
This study aims to address this gap by examining the association between MA and 90-day AIS readmission.Methods:Using the National Readmission Database between 2016 and 2019, we identified patients admitted with a principal or non-principal diagnosis of migraine. The primary outcome was subsequent AIS admission within 90 days.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content